(NYSE: VAPO) Vapotherm's forecast annual revenue growth rate of 26.77% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 10.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 71.5%.
Vapotherm's revenue in 2023 is $70,382,000.On average, 2 Wall Street analysts forecast VAPO's revenue for 2023 to be $2,382,702,629, with the lowest VAPO revenue forecast at $2,343,177,860, and the highest VAPO revenue forecast at $2,422,227,398.
In 2024, VAPO is forecast to generate $2,721,867,876 in revenue, with the lowest revenue forecast at $2,721,867,876 and the highest revenue forecast at $2,721,867,876.